New Collaboration to Evaluate Lower-Dose Gene Therapy Conditioning for Sickle Cell Disease

Jasper Therapeutics and Aruvant Sciences are studying the use of JSP191 used with ARU-1801 in patients with sickle cell disease.

The Potential of CAR T-Cell Therapy for Multiple Myeloma

James Hoffman, MD, discussed the significance of the approval of ide-cel for patients with multiple myeloma.

CAR T-Cell Therapy for Early-Relapsed Multiple Myeloma

Faith E. Davies, MD, discussed the potential of CAR T-cell therapies for the treatment of multiple myeloma.